| Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis D Madhavan, C Peng, M Wallwiener, M Zucknick, J Nees, S Schott, ... Carcinogenesis 37 (5), 461-470, 2016 | 153 | 2016 |
| Let-7g is involved in doxorubicin induced myocardial injury J Fu, C Peng, W Wang, H Jin, Q Tang, X Wei Environmental toxicology and pharmacology 33 (2), 312-317, 2012 | 41 | 2012 |
| Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer C Peng, M Wallwiener, A Rudolph, K Ćuk, U Eilber, M Celik, C Modugno, ... International journal of cancer 138 (10), 2499-2509, 2016 | 40 | 2016 |
| Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from China R Xu, W Wang, B Zhu, X Lin, D Ma, L Zhu, Q Zhao, Y Nie, X Cai, Q Li, ... BMC cancer 20, 1-10, 2020 | 32 | 2020 |
| Treatment patterns and direct medical costs of metastatic colorectal cancer patients: a retrospective study of electronic medical records from urban China L Shen, Q Li, W Wang, L Zhu, Q Zhao, Y Nie, B Zhu, D Ma, X Lin, X Cai, ... Journal of Medical Economics 23 (5), 456-463, 2020 | 31 | 2020 |
| S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer M Maierthaler, M Kriegsmann, C Peng, S Jauch, A Szabo, M Wallwiener, ... Experimental and molecular pathology 99 (1), 180-187, 2015 | 21 | 2015 |
| The effect of ethephon on immune system in male offspring of mice S Wang, H Jin, Q Tang, J Fu, Z Ren, C Peng, L Shang, W Hao, X Wei Environmental toxicology and pharmacology 49, 119-123, 2017 | 19 | 2017 |
| Plasma S100P level as a novel prognostic marker of metastatic breast cancer C Peng, H Chen, M Wallwiener, C Modugno, K Cuk, D Madhavan, ... Breast cancer research and treatment 157, 329-338, 2016 | 17 | 2016 |
| Quality-adjusted time without symptoms or toxicity (Q-TWiST) of patients with metastatic colorectal cancer (mCRC) treated with fruquintinib in the randomized phase III FRESCO … YX Bai, S Qin, J Li, Y Deng, L Yang, R Xu, H Zhong, Z Chen, H Pan, ... Journal of Clinical Oncology 36 (15_suppl), 3544-3544, 2018 | 1 | 2018 |
| S100p and hyaluronic acid as biomarkers for metastatic breast cancer B Burwinkel, R Yang, C Peng, A Schneeweiss US Patent App. 15/303,886, 2017 | 1 | 2017 |
| Quality-adjusted time without symptoms or toxicity (Q-TWiST) of patients with metastatic colorectal cancer (mCRC) treated with fruquintinib in a phase II clinical trial. J Li, R Xu, Y Bai, J Xu, T Liu, L Shen, L Wang, H Pan, R Han, Y Chen, ... Journal of Clinical Oncology 36 (4_suppl), 765-765, 2018 | | 2018 |
| Investigation of plasma hyaluronic acid and S100P as minimally invasive prognostic markers of metastatic breast cancer C Peng | | 2015 |
| Diagnostic, prognostic, and treatment monitoring value of plasma X in patients with metastatic breast cancer. C Peng, R Yang, D Madhavan, M Wallwiener, A Rudolph, ... Journal of Clinical Oncology 32 (26_suppl), 37-37, 2014 | | 2014 |
| Disease characteristics and treatment patterns of Chinese patients with colorectal cancer: a R Xu, W Wang, B Zhu, X Lin, D Ma, L Zhu, Q Zhao, Y Nie, X Cai, Q Li, ... | | |
